Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 6.02 USD -19.73% Market Closed
Market Cap: 340.9m USD
Have any thoughts about
Design Therapeutics Inc?
Write Note

Design Therapeutics Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Design Therapeutics Inc
Short-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Short-Term Investments
$260.6m
CAGR 3-Years
98%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Short-Term Investments
$28m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Short-Term Investments
$7.8B
CAGR 3-Years
49%
CAGR 5-Years
39%
CAGR 10-Years
35%

See Also

What is Design Therapeutics Inc's Short-Term Investments?
Short-Term Investments
260.6m USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Short-Term Investments amounts to 260.6m USD.

What is Design Therapeutics Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 3Y
98%

Over the last year, the Short-Term Investments growth was -14%. The average annual Short-Term Investments growth rates for Design Therapeutics Inc have been 98% over the past three years .

Back to Top